These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35305566)

  • 1. Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report.
    Moodie T; Alshaqi O; Alchaki A
    BMC Neurol; 2022 Mar; 22(1):107. PubMed ID: 35305566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report.
    Yorozuya T; Taya T; Yasuda K; Nagano Y; Shioya M; Chiba H; Takahashi H
    Thorac Cancer; 2020 Apr; 11(4):1090-1093. PubMed ID: 32045109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer.
    Wang L; Lou H; Li B; Li J; Yang YM
    Invest New Drugs; 2022 Feb; 40(1):151-156. PubMed ID: 34287773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report.
    Amano H; Miyamoto N; Shimura H; Sato DK; Fujihara K; Ueno S; Nakamura R; Ueno Y; Watanabe M; Hattori N; Urabe T
    BMC Neurol; 2014 Nov; 14():224. PubMed ID: 25434485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
    Loos J; Pfeuffer S; Pape K; Ruck T; Luessi F; Spreer A; Zipp F; Meuth SG; Bittner S
    J Neurol; 2020 Jun; 267(6):1632-1642. PubMed ID: 32055995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of longitudinal extensive transverse myelitis: immunotherapy related adverse effect
    Esechie A; Fang X; Banerjee P; Rai P; Thottempudi N
    Int J Neurosci; 2023 Dec; 133(10):1120-1123. PubMed ID: 35369847
    [No Abstract]   [Full Text] [Related]  

  • 10. A Rare Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Transverse Myelitis in a 40-Year-Old Patient With COVID-19.
    Doukas SG; Santos AP; Mir W; Daud S; Zivin-Tutela TH
    Cureus; 2022 Apr; 14(4):e23877. PubMed ID: 35530898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Longitudinally extensive transverse myelitis involving fifteen vertebral bodies positive for anti-myelin oligodendrocyte glycoprotein (MOG) antibody: a case report].
    Imai T; Shibata S; Shinohara K; Sakurai K; Horiuchi M; Hasegawa Y
    Rinsho Shinkeigaku; 2019 Jun; 59(6):375-378. PubMed ID: 31142714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
    Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive varicella-zoster virus myelitis presenting as longitudinally extensive transverse myelitis: a case report].
    Shiga Y; Kamimura T; Shimoe Y; Takahashi T; Kaneko K; Kuriyama M
    Rinsho Shinkeigaku; 2017 Oct; 57(10):579-583. PubMed ID: 28954973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
    Dubey D; Pittock SJ; Krecke KN; Morris PP; Sechi E; Zalewski NL; Weinshenker BG; Shosha E; Lucchinetti CF; Fryer JP; Lopez-Chiriboga AS; Chen JC; Jitprapaikulsan J; McKeon A; Gadoth A; Keegan BM; Tillema JM; Naddaf E; Patterson MC; Messacar K; Tyler KL; Flanagan EP
    JAMA Neurol; 2019 Mar; 76(3):301-309. PubMed ID: 30575890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019.
    Uchino K; Soga K; Shinohara K; Imai T; Motohashi I; Okuma H; Yamano Y
    Intern Med; 2023 May; 62(10):1531-1535. PubMed ID: 36858516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination.
    Dams L; Kraemer M; Becker J
    Mult Scler; 2022 Jun; 28(7):1159-1162. PubMed ID: 34931927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON).
    Saito G; Oya Y; Taniguchi Y; Kawachi H; Daichi F; Matsumoto H; Iwasawa S; Suzuki H; Niitsu T; Miyauchi E; Yokoi T; Yokoyama T; Uenami T; Sakata Y; Arai D; Okada A; Nagata K; Teraoka S; Kokubo M
    Lung Cancer; 2021 Nov; 161():86-93. PubMed ID: 34543942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
    Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive longitudinal acute transverse myelitis complicated by pulseless ventricular tachycardia and recent shingles vaccination.
    Meleis MM; Hahn SB; Carraro MN; Deutsch AB
    Am J Emerg Med; 2023 Jun; 68():213.e1-213.e3. PubMed ID: 37120396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.